Brief: Sprint Bioscience Announces Deal With Lilly Tunelab
23/07/2026 06:33
BRIEF-Sprint Bioscience Announces Deal With Lilly Tunelab July 23 (Reuters) - Sprint Bioscience AB SPRINT.ST:
SPRINT BIOSCIENCE ANNOUNCES AGREEMENT WITH LILLY TUNELAB TO ACCELERATE DRUG DEVELOPMENT
Source text: ID:nMFN6Jzq5y
Further company coverage: SPRINT.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Sprint Bioscience AB
See all newsBrief: Sprint Bioscience And Max IV Receive Funding From Vinnova
Brief: Sprint Bioscience Q2 Loss After Tax SEK 16.2 Million
Brief: Sprint Bioscience Announces Deal With Lilly Tunelab
Brief: Sprint Bioscience Partners With Lilly Tunelab For Drug Development
Brief: Sprint Bioscience Q1 Operating Loss SEK 14.3 Mln